CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Niklason Laura E President, CEO and Director | Sale | −261,369 | $4.40 | $1.2M | 1,730,884 |
| 2024-11-20 | Dougan Brady W Director | Sale | −261,369 | $4.40 | $1.2M | 1,730,884 |
| 2024-11-19 | Niklason Laura E President, CEO and Director | Purchase | +1,797 | $4.44 | $8K | 243,851 |
| 2024-11-19 | Dougan Brady W Director | Purchase | +1,797 | $4.44 | $8K | 243,851 |
| 2024-11-19 | Niklason Laura E President, CEO and Director | Sale | −427,459 | $4.34 | $1.9M | 1,992,253 |
| 2024-11-19 | Dougan Brady W Director | Sale | −427,459 | $4.34 | $1.9M | 1,992,253 |
| 2024-11-18 | Niklason Laura E President, CEO and Director | Sale | −811,172 | $4.44 | $3.6M | 2,419,712 |
| 2024-11-18 | Dougan Brady W Director | Sale | −811,172 | $4.44 | $3.6M | 2,419,712 |
| 2024-09-13 | Green Charles Bruce Director | Option exercise | +1,200 | $4.09 | $5K | 2,400 |
| 2024-09-13 | Green Charles Bruce Director | Option exercise · Stock Options (right to buy) | −1,200 | 10,600 | ||
| 2024-09-10 | Sebelius Kathleen Director | Option exercise | +4,521 | $4.34 | $20K | 43,910 |
| 2024-09-10 | Sebelius Kathleen Director | Sale | −3,634 | $5.41 | $20K | 40,276 |
| 2024-09-10 | Sebelius Kathleen Director | Option exercise | +2,479 | $3.35 | $8K | 42,755 |
| 2024-09-10 | Sebelius Kathleen Director | Sale | −1,548 | $5.39 | $8K | 41,207 |
| 2024-09-10 | Sebelius Kathleen Director | Option exercise · Stock Options (right to buy) | −4,521 | 3,979 | ||
| 2024-09-10 | Sebelius Kathleen Director | Option exercise · Stock Options (right to buy) | −2,479 | 6,021 | ||
| 2024-09-10 | Dougan Brady W Director | Sale | −288,674 | $5.23 | $1.5M | 3,230,884 |
| 2024-09-10 | Niklason Laura E President, CEO and Director | Sale | −288,674 | $5.23 | $1.5M | 3,230,884 |
| 2024-09-09 | Dougan Brady W Director | Sale | −157,704 | $5.42 | $855K | 3,519,558 |
| 2024-09-09 | Niklason Laura E President, CEO and Director | Sale | −157,704 | $5.42 | $855K | 3,519,558 |
Page 4 of 17 · 330 trades